Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels

Pediatric and Developmental Pathology

Volumn 10, Issue 3, 2007, Pages 233-238

  Cajaiba, Mariana M ^a   Sarita Reyes, Carmen ^a   Zambrano, Eduardo ^a   Reyes Múgica, Miguel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha fetoprotein; Beckwith Wiedemann syndrome; Hyperinsulinemic hypoglycemia; Mesenchymal liver hamartoma

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; DIAZOXIDE; HYDROCORTISONE; LIVER ENZYME; OCTREOTIDE;

ADRENAL GLAND; ARTICLE; BECKWITH WIEDEMANN SYNDROME; BLOOD TESTIS BARRIER; CANCER DIAGNOSIS; CASE REPORT; CELL MATURATION; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRON MICROSCOPY; FEMALE; HAMARTOMA; HEPATOBLASTOMA; HISTOLOGY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY DISEASE; KIDNEY SIZE; LIVER CELL; LIVER NODULE; LIVER RESECTION; LIVER TUMOR; MESENCHYMOMA; MOTOR DEVELOPMENT; MULTIPLE ENDOCRINE ADENOMATOSIS; NERVOUS SYSTEM DEVELOPMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OMPHALOCELE; PANCREAS DISEASE; PANCREAS RESECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TOTAL PARENTERAL NUTRITION; BLOOD; CYTOCHEMISTRY; DIFFERENTIAL DIAGNOSIS; LIVER DISEASE; MESODERM; METABOLISM; PATHOLOGY; RADIOGRAPHY; TREATMENT OUTCOME; ULTRASTRUCTURE;

ALPHA-FETOPROTEINS; BECKWITH-WIEDEMANN SYNDROME; DIAGNOSIS, DIFFERENTIAL; FEMALE; HAMARTOMA; HEPATOBLASTOMA; HEPATOCYTES; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LIVER DISEASES; LIVER NEOPLASMS; MESODERM; TREATMENT OUTCOME;

EID: 34447617544     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/06-07-0128.1     Document Type: Article

References (26)

1. Beckwith JB. Macroglossia, omphalocele, adrenal cytomegaly, gigantism, and hyperplastic visceromegaly. In: D Bergsma, ed. The first Conference on the Clinical Delineation of Birth Defects. Birth Defects: Original Article Series, vol 5. New York: National Foundation 1969;188-197.
2. Pettenati MJ, Haines JL, Higgins RR, Wappner RS, Palmer CG, Weaver DD. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet 1986;74:143-154.
3. Martinez y Martinez R, Martinez-Carboney R, Ocampo-Campos R, et al. Wiedemann-Beckwith syndrome: clinical, cytogenetical and radiological observations in 39 new cases. Genet Counsel 1992;3:67-76.
4. Elliot M, Bayly R, Cole T, Temple IK, Maher ER. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clin Genet 1994;46:168-174.
5. Cohen MM. Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 2005;8:287-304.
6. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998;132:398-400.
7. Stocker JT, Ishak KG. Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature. Pediatr Pathol 1983;1:245-267.
8. Stringer MD, Alizai NK. Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg 2005;40:1681-1690.
9. Boman F, Bossard C, Fabre M, Diab N, Bonnevalle M, Boccon-Gibod L. Mesenchymal hamartomas of the liver may be associated with increased serum alpha foetoprotein concentrations and mimic hepatoblastomas. Eur J Pediatr Surg 2004;14:63-66.
10. Clericuzio CL, Chen E, McNeil DE, et al. Serum α-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 2003;143:270-272.
11. Everman DB, Shuman C, Dzolganovski B, O'Riordan MA, Weksberg R, Robin NH. Serum α-fetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 2000;137:123-127.
12. Rump P, Zeegers MPA, Van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: a review and meta-analysis. Am J Med Genet 2005;136A:95-104.
13. McNeil DE, Brown M, Ching A, DeBaun MR. Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model. Med Pediatr Oncol 2001;37:349-356.
14. Blohm ME, Vesterling-Horner D, Calaminus G, Gobel U. Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. Pediatr Hematol Oncol 1998;15:135-142.
15. Murray JD, Ricketts RR. Mesenchymal hamartoma of the liver. Am Surg 1998;64:1097-1103.
16. Fukuzawa R, Umezawa A, Morikawa Y, Kim KC, Nagai T, Hata JI. Nesidioblastosis and mixed hamartoma of the liver in Beckwith-Wiedemann syndrome: case study including analysis of H19 methylation and insulin-like growth factor 2 genotyping and imprinting. Pediatr Dev Pathol 2001;4:381-390.
17. Sharif K, Ramani P, Lochbuhler H, Grundy R, Ville de Goyet J. Recurrent mesenchymal hamartoma associated with 19q translocation. A call for more radical surgical resection. Eur J Pediatr Surg 2006;16:64-67.
18. Takayasu H, Horie H, Hiyama E, et al. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin Cancer Res 2001;7:901-908.
19. Ranganathan S, Tan X, Monga SP. Beta-catenin and met deregulation in childhood hepatoblastomas. Pediatr Dev Pathol 2005;8:435-447.
20. DeBaun MR, King AA, White N. Hypoglycemia in Beckwith-Wiedemann syndrome. Semin Perinatal 2000;24:164-171.
21. Suchi M, MacMullen C, Thornton PS, Ganguly A, Stanley CA, Ruchelli ED. Histopathology of congenital hyperinsulinism: retrospective study with genotype correlation. Pediatr Dev Pathol 2003;6: 322-333.
22. Goossens A, Gepts W, Saudubray JM, Bonnefont JP, Nihoul F, Heitz PU, Kloppel G. Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hyperglycemia. Am J Surg Pathol 1989;13:766-775.
23. Laidlaw GF. Nesidioblastoma, the islet cell tumor of the pancreas. Am J Pathol 1938;14:125-134.
24. Hussain K, Cosgrove KE, Shepherd RM, et al. Hyperinsulinemic hypoglycemia in Beckwith-Wiedemann syndrome due to defects in the function of pancreatic β-cell adenosine triphosphate-sensitive potassium channels. J Clin Endocrinol Metab 2005;90:4376-4382.
25. Thomas P, Ye Y, Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Gen 1996;5:1809-1812.
26. Verkarre V, Fournet JC, Lonlay P, et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998;102:1286-1291.